COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 315.5 | 4 | 0143-0498 | 530.91 | 497.54 | 426 | 78.43 | 0.870 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 265.9 | 4 | 0144-0508 | 936.11 | 508.18 | 411 | 76.43 | 0.884 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 411.7 | 4 | 0145-0516 | 640.42 | 515.71 | 391 | 73.60 | 0.907 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 332.0 | 4 | 0146-0518 | 385.44 | 518.92 | 445 | 83.98 | 0.793 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 265.1 | 4 | 0147-0526 | 569.04 | 526.32 | 431 | 80.33 | 0.839 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 251.9 | 4 | 0148-0525 | 428.94 | 525.80 | 418 | 80.33 | 0.814 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 229.9 | 4 | 0149-0528 | 701.21 | 528.02 | 431 | 79.50 | 0.857 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 372.3 | 4 | 0150-0535 | 118.78 | 535.26 | 432 | 80.91 | 0.829 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 419.8 | 4 | 0151-0535 | 367.11 | 534.85 | 449 | 81.74 | 0.844 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 319.7 | 4 | 0152-0538 | 154.87 | 538.00 | 401 | 75.74 | 0.878 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 253.5 | 4 | 0153-0542 | 403.90 | 541.72 | 447 | 84.33 | 0.790 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 305.2 | 4 | 0154-0546 | 617.77 | 545.48 | 421 | 78.67 | 0.855 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 410.0 | 4 | 0155-0553 | 247.29 | 552.85 | 707 | 100.23 | 0.884 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 287.5 | 4 | 0156-0546 | 851.67 | 546.21 | 400 | 76.18 | 0.866 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 271.5 | 4 | 0157-0551 | 755.90 | 550.92 | 400 | 75.01 | 0.893 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 1238.0 | 4 | 0158-0555 | 509.69 | 555.50 | 513 | 86.33 | 0.865 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 244.9 | 4 | 0159-0566 | 449.55 | 566.71 | 846 | 114.47 | 0.811 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 315.7 | 4 | 0160-0565 | 325.54 | 565.58 | 446 | 78.91 | 0.900 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 270.4 | 4 | 0161-0565 | 718.66 | 565.16 | 417 | 77.01 | 0.884 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 324.1 | 4 | 0162-0578 | 581.05 | 578.21 | 405 | 77.26 | 0.853 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 267.1 | 4 | 0163-0584 | 352.77 | 585.09 | 409 | 78.91 | 0.825 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 367.3 | 4 | 0164-0586 | 644.49 | 587.18 | 809 | 110.81 | 0.828 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 323.7 | 4 | 0165-0599 | 386.32 | 598.68 | 902 | 122.02 | 0.761 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 311.0 | 4 | 0166-0597 | 820.30 | 597.28 | 403 | 79.50 | 0.801 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 221.1 | 4 | 0167-0597 | 902.14 | 597.37 | 399 | 74.43 | 0.905 |